CYP2C19 PHENOTYPE, RESPONSE RATE, AND ADVERSE EVENTS OF (ES)CITALOPRAM IN A PEDIATRIC COHORT.

被引：0
|
作者：
Van Driest, S. [1 ]
Aka, I. [1 ]
Neely, K. [1 ]
机构：
[1] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PGRN-019
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [1] CYP2C19 PHENOTYPE, RESPONSE RATE, AND ADVERSE EVENTS OF (ES)CITALOPRAM IN A PEDIATRIC COHORT.
    Van Driest, S.
    Aka, I.
    Neely, K.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S56 - S56
  • [2] CYP2C19 variation and citalopram response
    Mrazek, David A.
    Biernacka, Joanna M.
    O'Kane, Dennis J.
    Black, John L.
    Cunningham, Julie M.
    Drews, Maureen S.
    Snyder, Karen A.
    Stevens, Susanna R.
    Rush, Augustus John
    Weinshilboum, Richard M.
    [J]. PHARMACOGENETICS AND GENOMICS, 2011, 21 (01): : 1 - 9
  • [3] CYP2C19 PHENOTYPE AND ADVERSE EVENTS DURING SERTRALINE TREATMENT IN CHILDREN AND ADOLESCENTS.
    Neely, K.
    Aka, I.
    Maxwell-Horn, A.
    Roden, D.
    Van Driest, S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S56 - S56
  • [4] CYP2C19 PHENOTYPE AND ADVERSE EVENTS DURING SERTRALINE TREATMENT IN CHILDREN AND ADOLESCENTS.
    Neely, K.
    Aka, I.
    Maxwell-Horn, A.
    Roden, D.
    Van Driest, S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S17 - S17
  • [5] Genetic polymorphism of CYP2C19 gene in the stanislas cohort.: A link with inflammation
    Bertrand-Thiebault, C.
    Berrahmoune, H.
    Thomspson, A.
    Marie, B.
    Droesch, S.
    Siest, G.
    Foernzler, D.
    Visvikis-Siest, Sophie
    [J]. ANNALS OF HUMAN GENETICS, 2008, 72 : 178 - 183
  • [6] Pharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19
    Yu, BN
    Chen, GL
    He, N
    Ouyang, DS
    Chen, XP
    Liu, ZQ
    Zhou, HH
    [J]. DRUG METABOLISM AND DISPOSITION, 2003, 31 (10) : 1255 - 1259
  • [7] CYP2C19 Genotype and Cardiovascular Events
    Siasos, Gerasimos
    Tousoulis, Dimitris
    Stefanadis, Christodoulos
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (14): : 1483 - 1484
  • [8] Omeprazole-induced acute interstitial nephritis is not related to CYP2C19 genotype or CYP2C19 phenotype
    Helsby, Nuala A.
    Lo, Wing-Yee
    Simpson, Ian J.
    Voss, David M.
    Logan, Kaye E.
    Searle, Martin
    Schollum, John B. W.
    de Zoysa, Janak R.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (05) : 516 - 519
  • [9] CYP2C19 Genotype and Cardiovascular Events Reply
    Holmes, Michael V.
    Hingorani, Aroon D.
    Casas, Juan P.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (14): : 1484 - 1485
  • [10] The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19☆35 and CYP2C19☆2 Alleles
    Chaudhry, Amarjit S.
    Prasad, Bhagwat
    Shirasaka, Yoshiyuki
    Fohner, Alison
    Finkelstein, David
    Fan, Yiping
    Wang, Shuoguo
    Wu, Gang
    Aklillu, Eleni
    Sim, Sarah C.
    Thummel, Kenneth E.
    Schuetz, Erin G.
    [J]. DRUG METABOLISM AND DISPOSITION, 2015, 43 (08) : 1226 - 1235
12345